Analysts are optimistic about the company due to strong AI demand and strategic positioning. William Blair and Piper Sandler reiterated Buy/Overweight ratings, with the latter setting a $470 price target following the acquisition of Semrush to boost marketing tools. The company is aggressively integrating AI into its offerings, driving investor interest. A partnership was also announced to develop culturally relevant GenAI for the Middle East. Despite slightly lowering the consensus price target, analysts point to strong results, product innovation, and rising revenue growth expectations.